Abstract:Objective To examine the sex differences in prescribing patterns of psychotropic drugs and drug-induced side effects in schizophrenia patients in China. Methods Using the same design and a standardized protocol as in 2002 and 2006, the cross-sectional survey was conducted from July to August, 2012 in 45 psychiatric hospitals/centers in 10 provinces and municipalities in China. Inpatients and outpatients with schizophrenia were consecutively screened for eligibility for this study. Sociodemographic characteristics and prescription pattern were collected by using a modified questionnaire for the study. Data comparisons between male and female were performed with univariate analysis. Multiple logistic regression analysis was employed to determine the gender differences in prescription pattern and drug-induced side effects. Results The sample consisted of 2 260 male and 1 979 female patients. Univariate analyses showed that male patients were younger than female patients(t=5.398), having an earlier age at onset(t=5.662), higher percentage of being employed(χ2=31.597), and more negative symptoms(χ2=10.814)and aggressive behavior (χ2=5.816), more likely to receive clozapine (23.9%(472/1 979) vs. 28.5%(645/2 260),χ2=11.955), higher antipsychotic doses(476 mg vs. 514 mg,F=14.003), less use of antidepressants (7.9%(156/1 979) vs. 6.0%(136/2 260),χ2=5.722)and benzodiazepines(23.9%(472/1 979)vs. 20.0%(451/2 260),χ2=9.396), more frequent tardive dyskinesia(1.3%(25/1 979)vs. 2.1%(47/2 260),χ2=4.212)and less weight gain(11.0%(218/1 979)vs. 7.7%(173/2 260),χ2=14.233)and prolactin elevation(3.2%(63/1 979)vs. 1.7%(39/2 260),χ2=9.548;all P<0.05). In multivariate analyses, greater rate of clozapine use (OR=1.268,P=0.001), less rate of benzodiazepines use(OR=0.841,P=0.025) and antidepressants(OR=0.78,P=0.045),higher rate of tardive dyskinesia(OR=1.879,P=0.014)and less weight gain (OR=0.669,P=0.001) and prolactin elevation (OR=0.527,P=0.003) were independently associated with the male sex. Conclusion Gender is one of the independent contributors to psychotropic prescription pattern and side effects of antipsychotics in Chinese schizophrenia patients. Gender differences should be given more attention in research and clinical practice.

The second cross-sectional study on antipsychotic drug patterns of schizophrenia in China

Antipsychotic drug patterns of schizophrenia in China:a cross-sectioned study

Patterns of Antipsychotic Prescriptions in Patients with Schizophrenia in China: A National Survey

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China.

The second cross-sectioned study on antidepressants patterns of depression in China

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

Sex Differences in Pharmacotherapy of Schizophrenia:Findings from National Survey 2012 on Use of Psychotropic Medications

Adjunctive Antidepressant Use In Schizophrenia In China: A National Survey (2002-2012)

A cross-sectional study on treatment patterns of bipolar disorders in China in 2006

A survey of antipsychotic usage in treatment of schizophrenia in China 2006

Trends of Antipsychotic Drugs Use in Schizophrenia Patients from Hebei Province

Present Survey on Antipsychotic Medications to the Patients with Schizophrenia in Hebei Province

Antipsychotic prescription patterns among schizophrenia patients in Guangdong Province, China's 686 program: A retrospective study

From strict quarantine to an optimized policy: Are we psychologically prepared?

Anticholinergic Use Trends in 14,013 Patients with Schizophrenia from Three National Surveys on the Use of Psychotropic Medications in China (2002–2012)

A survey of antipsychotics combination therapy and its related factors in China 2006

A Cross-Sectional Study on Medication Treatment Patterns of Bipolar Disorder in China

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

Use of clozapine for the treatment of schizophrenia: findings of the 2006 research on the china psychotropic prescription studies

Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009).